Institutional Ownership Verve Therapeutics, Inc. (VERV)
This table provides information about the institutional ownership of Verve Therapeutics, Inc. (VERV). We have compiled data on the 196 institutions that hold shares in the stock, with a total of 72.2 Million shares, which have been reported (via 13F filing form) to have a value of $804 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Alphabet Inc.
Mountain View, CA |
Jul 31, 2025 Q2 2025 |
12,168,489
shares
|
$135 Million
8.86% of portfolio
|
Q2 2025
Reduced 1.46%
|
|
Pentwater Capital Management LP
Naples, FL |
Aug 14, 2025 Q2 2025 |
6,720,000
shares
|
$74.8 Million
0.5% of portfolio
|
Q2 2025
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
6,620,004
shares
|
$73.7 Million
0.0% of portfolio
|
Q2 2024
Added 23.2%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
4,191,854
shares
|
$46.7 Million
0.0% of portfolio
|
Q2 2025
Added 5.99%
|
|
Casdin Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
4,095,571
shares
|
$45.6 Million
6.45% of portfolio
|
Q2 2025
Added 2.5%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
3,612,000
shares
|
$40.2 Million
0.18% of portfolio
|
Q2 2025
Added 296.05%
|
|
Alpine Associates Management Inc.
Englewood Cliffs, NJ |
Aug 05, 2025 Q2 2025 |
2,738,212
shares
|
$30.5 Million
1.68% of portfolio
|
Q2 2025
New holding
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,626,859
shares
|
$29.2 Million
0.0% of portfolio
|
Q2 2025
Reduced 15.02%
|
|
Arch Venture Management, LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
2,008,809
shares
|
$22.4 Million
11.95% of portfolio
|
Q3 2022
Reduced 19.93%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,870,522
shares
|
$20.8 Million
0.0% of portfolio
|
Q2 2025
Added 1319.5%
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Aug 18, 2025 Q2 2025 |
1,747,598
shares
|
$19.5 Million
0.08% of portfolio
|
Q2 2025
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,704,394
shares
|
$19 Million
0.0% of portfolio
|
Q2 2025
Added 1.31%
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,691,530
shares
|
$18.8 Million
0.19% of portfolio
|
Q4 2023
Added 19.41%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
1,611,913
shares
|
$17.9 Million
0.01% of portfolio
|
Q2 2025
Added 21.68%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,482,642
shares
|
$16.5 Million
0.0% of portfolio
|
Q2 2025
Added 4.92%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,315,771
shares
|
$14.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 21.29%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,047,600
shares
|
$11.7 Million
0.02% of portfolio
|
Q2 2025
Added 479.42%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
817,532
shares
|
$9.1 Million
0.0% of portfolio
|
Q2 2025
Added 83.92%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
812,360
shares
|
$9.04 Million
0.02% of portfolio
|
Q2 2025
Added 114.01%
|
|
Redmile Group, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
740,261
shares
|
$8.24 Million
1.01% of portfolio
|
Q2 2025
Reduced 38.68%
|
|
Nordea Investment Management Ab
Stockholm, V7 |
Jul 29, 2025 Q2 2025 |
675,849
shares
|
$7.52 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
592,436
shares
|
$6.59 Million
0.0% of portfolio
|
Q2 2025
Added 4.27%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
588,830
shares
|
$6.55 Million
0.0% of portfolio
|
Q2 2025
Reduced 5.23%
|
|
Weiss Asset Management LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
538,422
shares
|
$5.99 Million
0.09% of portfolio
|
Q2 2025
New holding
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
507,127
shares
|
$5.64 Million
0.0% of portfolio
|
Q2 2025
Reduced 45.1%
|